InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,596.64
(
0.08%
)
US TECH 100
18,907.00
(
0.43%
)
Dow Jones
41,238.67
(
-0.23%
)
Brent Oil
77.12
(
-2.09%
)
Bitcoin
58,159.34
(
-2.08%
)
Post# of 83010
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

beach_trades

Send PM Follow Ignore
Followers 425
Posts 20207
Boards Moderated 1
Alias Born 02/22/2010

beach_trades

Re: softballdaddy post# 39080

Wednesday, 07/18/2012 9:22:04 AM

Wednesday, July 18, 2012 9:22:04 AM

Post# of 83010
HEB News Breaks Hemispherx files NDA in Argentina for Ampligen to treat CFS

July 18, 2012

08:10 EDT HEB theflyonthewall.com: Hemispherx files NDA in Argentina for Ampligen to treat CFS

Hemispherx Biopharma announced that it has submitted a new drug application, or NDA, to ANMAT, or Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica, the agency responsible for the national regulation of drugs, foods and medical technology in Argentina, under the ANMAT's Orphan Drug regulations. Ampligen is an experimental drug currently undergoing clinical development for the treatment of Chronic Fatigue Syndrome, or CFS, in the U.S. :theflyonthewall.com

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up